BMS-186511
BMS-186511 is a farnesyltransferase (FT) inhibitor and shows anticancer activity[1].
Product Specifications
CAS Number
167467-53-0
UNSPSC
12352211
Target
Farnesyl Transferase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bms-186511.html
Smiles
CSCC[C@@H](C(OC)=O)NC([C@H](C(C)C)NC([C@H](C(C)C)NC(CCP(C/C=C(C)/CC/C=C(C)/CC/C=C(C)\C)(O)=O)=O)=O)=O
Molecular Formula
C34H60N3O7PS
Molecular Weight
685.89
References & Citations
[1]Yan N, et al. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype. Cancer Res. 1995 Aug 15;55 (16) :3569-75.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSM041306-01 10 µg
Recombinant Mouse MGL2/CD301b Protein (His Tag)
Sign In for Pricing
View Details PKSM041306-02 50 µg
Recombinant Mouse MGL2/CD301b Protein (His Tag)
Sign In for Pricing
View Details 
BNC473435-100 1x 100 µL
CELA3B / ELA3B (Pancreatic Function Marker) (rCELA3B/1811), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSR030186 50 µg
Recombinant Rat IL23R/IL23 Receptor Protein (Fc Tag)
Sign In for Pricing
View Details 